rsz_drsingal_2013 Dr. Singal is an Associate Professor of Medicine and Co-Director of the UAB Porphyria Center. He completed residency at the Mount Sinai School of Medicine NY, gastroenterology fellowship and master’s degree in clinical sciences at the  UTMB in TX, and AASLD sponsored advanced fellowship in Transplant Hepatology at the Mayo Clinic, MN.  He is board certified in internal medicine, gastroenterology, and transplant hepatology. Dr. Singal is a leading expert in alcoholic liver disease and his other research interests include non-alcoholic fatty liver disease, porphyria,acute kidney injury in cirrhosis. In addition to various industry sponsored clinical trials, he is the PI on translational research studies funded by the American College of Gastroenterology, NIAAA and NIDDK of the NIH. He collaborates within UAB with the free radical center, O'Brien center of acute kidney injury, genetics core, and microbiome core, and outside UAB with the NIAAA funded consortia on alcoholic hepatitis. He serves on many national committees including practice guidelines of the American College of Gastroenterology and research award committees of the American Association for Study of Liver Diseases and the American Gastroenterological Association. In addition, Dr. Singal regularly mentors medical students, residents and fellows with regular presentations at the national meetings helping them to advance in their respective careers. Dr. Singal actively participates in faculty practice at the UAB Liver Center to see and manage patients with various liver diseases.  

Physician Provider Profile

Recent publications:  

1. Singal AK, Hasanin M, Kaif M, Wiesner R, Kuo YF. Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation.Transplantation 2016; 100: 607-12. PMID 26479282
2.  Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Ulrich S, Daly A, Day CP, Kuo YF, Singal AK. PNPLA3 gene polymorphisms is associated with predisposition to and severity of alcoholic liver disease. Am J Gastroenterol 2015, 110: 846-56. PMID 25964223
3. Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis.Gastroenterology 2015; 149: 958-70.
4. Chacko BK, Kramer PA, Ravi S, Benavides GA, Mitchell T, Dranka BP, Ferrick D, Singal AK, Ballinger SW, Bailey SM, Hardy RW, Zhang J, Zhi D, Darley-Usmar VM. The bioenergetic health index: a new concept in mitochondrial translational research. Clin Sci 2014; 127: 367-73. PMID 24895057
5. Singal AK, Parker C, Bowden C, Thapar M, Liu L, Mcguire BM. Liver transplantation in the management of porphyria. Hepatology 2014; 60: 1082-9. PMID 24700519 
6. Singal AK, Csilla H, Lee C, Grady J, freeman DH, Anderson KE. Low dose hydroxychloroquine is as effective as phlebotomy in the treatment of porphyria cutanea tarda. Clin Gastroenterol Hepatol 2012; 10: 1402-9. NIHMS 417780. PMCID 22985607.
7.  Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis based on UNOS database. Hepatology 2012; 55: 1398-1405. PMID 22213344

Pubmed publications: